References
- Beale MA, Marks M, Cole MJ, et al. Global phylogeny of Treponema pallidum lineages reveals recent expansion and spread of contemporary syphilis. Nat Microbiol. 2021;6(12):1549–1560.
- Xu M, Xie Y, Zheng K, et al. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of Treponema pallidum. Front Immunol. 2021;12:759474.
- Knaute DF, Graf N, Lautenschlager S, Weber R, Bosshard PP. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis. 2012;55(12):1615–1622.
- Tong ML, Lin LR, Liu GL, et al. Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS One. 2013;8(7):e70102.
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
- Janier M, Unemo M, Dupin N, Tiplica GS, Potocnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2021;35(3):574–588.
- Wu KX, Wang XT, Hu XL, et al. LncRNA-ENST00000421645 Upregulates Kank1 to Inhibit IFN-gamma Expression and Promote T Cell Apoptosis in Neurosyphilis. Front Microbiol. 2021;12:749171.
- Gonzalez H, Koralnik IJ, Marra CM. Neurosyphilis. Semin Neurol. 2019;39(4):448–455.
- Skalnaya A, Fominykh V, Ivashchenko R, et al. Neurosyphilis in the modern era: literature review and case series. J Clin Neurosci. 2019;69:67–73.
- Wong T, Fonseca K, Chernesky MA, Garceau R, Levett PN, Serhir B. Canadian Public Health Laboratory Network laboratory guidelines for the diagnosis of neurosyphilis in Canada. Can J Infect Dis Med Microbiol. 2015;26:18A–22A.
- Musher DM. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis. 1991;163(6):1201–1206.
- Qi Y, Jiang Z, Xie D, Lei N, Cai Z. Status epilepticus with focal neurologic deficits: a rare presentation of Neurosyphilis. Int J Infect Dis. 2022;117:345–348.
- Che KF, Tengvall S, Levanen B, et al. Interleukin-26 in antibacterial host defense of human lungs. Effects on neutrophil mobilization. Am J Respir Crit Care Med. 2014;190(9):1022–1031.
- Miot C, Beaumont E, Duluc D, et al. IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells. Gut. 2015;64(9):1466–1475.
- Beaumont E, Larochette V, Preisser L, et al. IL-26 inhibits hepatitis C virus replication in hepatocytes. J Hepatol. 2022;76(4):822–831.
- Janier M, Hegyi V, Dupin N, et al. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2014;28(12):1581–1593.
- Dong X, Zhang J, Yang F, Liu J, Peng Y, Ge Y. CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance. J Clin Lab Anal. 2021;35(11):e24016.
- Peermohamed S, Kogilwaimath S, Sanche S. Neurosyphilis. CMAJ. 2020;192(29):E844.
- Chow F. Neurosyphilis. Continuum. 2021;27(4):1018–1039.
- Tuddenham S, Katz SS, Ghanem KG. Syphilis Laboratory Guidelines: performance Characteristics of Nontreponemal Antibody Tests. Clin Infect Dis. 2020;71(Suppl 1):S21–S42.
- Gudowska-Sawczuk M, Mroczko B. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: a Review of Its Diagnostic Significance. Int J Mol Sci. 2020;21:8.
- Xiang Y, Xin J, Le W, Yang Y. Neurogranin: a Potential Biomarker of Neurological and Mental Diseases. Front Aging Neurosci. 2020;12:584743.
- Alberto C, Deffert C, Lambeng N, et al. Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis. Microbiol Spectr. 2022;10(1):e0147721.
- Li W, Han J, Zhao P, et al. Predicting asymptomatic neurosyphilis using peripheral blood indicators. BMC Infect Dis. 2021;21(1):1191.
- Braum O, Pirzer H, Fickenscher H. Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells. Antiinflamm Antiallergy Agents Med Chem. 2012;11(3):221–229.
- Donnelly RP, Sheikh F, Dickensheets H, Savan R, Young HA, Walter MR. Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev. 2010;21(5):393–401.
- Luo L, Jiang L, Tian Z, Zhang X. The serum interleukin-26 level is a potential biomarker for chronical hepatitis B. Medicine. 2020;99(1):e18462.